产品分类
N-亚硝基帕罗西汀---上海维亦特生物
发表时间：2025-11-04| 货号 | 中文名 | 英文名 | CAS |
| WY-USP-1A05240 | N-亚硝基帕罗西汀 | N-Nitroso Paroxetine ((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-nitrosopiperidine) | 2361294-43-9 |
| WY-USP-1A05230 | N-亚硝基帕罗西汀溶液 USP标准品 | N-Nitroso Paroxetine Solution((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-nitrosopiperidine) | 2361294-43-9 |
| WY-USP-1A03060 | 帕罗西汀 USP标准品 | Paroxol ((4R,3S)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol) | 105812-81-5 |
| WY-USP-1A03050 | 帕罗西汀甲氧基类似物 USP标准品 | Paroxetine Methoxy (3R,4S)-Enantiomer Hydrochloride ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride) | N/A |
| WY-USP-1A02990 | 盐酸帕罗西汀哌啶甲醇类似物 USP标准品 | Paroxetine Hydrochloride Piperidinemethanol Analog (((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methanol, hydrochloride) | 220548-73-2 |
| WY-USP-1A03000 | 盐酸帕罗西汀儿茶酚类似物 USP标准品 | Paroxetine Hydrochloride Catechol Analog (4-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzene-1,2-diol, hydrochloride) | 1394861-12-1 |
| WY-USP-1A03010 | 苯氧羰基帕罗西汀 USP标准品 | N-Phenoxycarbonyl Paroxetine (phenyl (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate) | 253768-88-6 |
| WY-USP-1A03020 | (3S，4S)-帕罗西汀 USP标准品 | (3S,4S)-Paroxol (((3S, 4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol) | 100332-20-5 |
| WY-USP-1A03030 | (3R，4R)-帕罗西汀 USP标准品 | (3R,4R)-Paroxol (((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol) | 100332-12-5 |
| WY-USP-1500218 | 帕罗西汀盐酸盐 USP标准品 | Paroxetine Hydrochloride | 110429-35-1 |
| WY-USP-1500353 | 帕罗西汀系统适用性混合物A USP标准品 | Paroxetine System Suitability Mixture A | N/A |
| WY-USP-1500284 | 帕罗西汀相关化合物G USP标准品 | Paroxetine Related Compound G ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4''-fluorophenyl-4'-phenyl)piperidine hydrochloride) | N/A |
| WY-USP-1500273 | 帕罗西汀相关化合物F USP标准品 | Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine) | 110429-36-2 |
| WY-USP-1500207 | 帕罗西汀相关化合物E USP标准品 | Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride) | 1012886-75-7 |
| WY-USP-1500251 | 帕罗西汀相关化合物D USP标准品 | Paroxetine Related Compound D ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride | N/A |
| WY-USP-1500240 | 帕罗西汀相关化合物C USP标准品 | Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride) | 130855-30-0 |
| WY-USP-1500230 | 帕罗西汀相关化合物B USP标准品 | Paroxetine Related Compound B((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride) | N/A |
